Company Description

Replicor is a clinical-stage biopharmaceutical company developing NUCLEIC ACID POLYMERS (NAPs). These compounds are oligonucleotides whose antiviral activity is strictly dependent on the sequence-independent activity of phosphorothioate oligonucleotides as biocompatible polymers that interact with exposed hydrophobic surfaces in proteins.